Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.745 USD | +6.81% |
|
+6.03% | -69.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.00% | 268M | |
+2.08% | 95.18B | |
-4.34% | 37.55B | |
-10.03% | 33.75B | |
+78.96% | 28.2B | |
-14.05% | 15.63B | |
-2.01% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on Revance Therapeutics to $41 From $48, Maintains Buy Rating